Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma

ConditionMelasma

Trial statusNot yet recruiting

Trial phasePhase 2, Phase 3

Trial typeInterventional

Biological sexFemale

Age18-50

SponsorAssiut University

About this trial

In this study, the investigators evaluate the potential efficacy of TXA alone and microneedling assisted with glutathione alone versus combination of oral tranexamic acid and glutathione-assisted microneedling in the treatment of melasma

Eligibility criteria

Qualifiers

• female patients

18/50 years old

facial melasma

Disqualifiers

pregnancy

lactation.

History of any bleeding,

clotting disorder

Trial design

Treatments tested in this trial

microneedling
Oral tranexamic acid
Glutathione

Treatment groups

42 Participants

are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov